Mucus Relief D
NDC 0363-7064, Guaifenesin and Pseudoephedrine HCL, tablet, extended release, from Walgreens Company.
- Product NDC
- 0363-7064
- Status
- Listed
- Labeler
- Walgreens Company
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA208369
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0363-7064 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN1200 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE120 mg/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0363-7064-24 | 00363706424 | 4 BLISTER PACK in 1 CARTON (0363-7064-24) / 6 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| 0363-7064-30 | 00363706430 | 2 BLISTER PACK in 1 CARTON (0363-7064-30) / 12 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0363-7064 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0363-7064 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0363-7064. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.